ShojiKKomuroHKobayashiY, et al. An infant with human parechovirus type 3 infection with a distinctive rash on the extremities. Pediatr Dermatol. 2014;31(2):258-259. doi:10.1111/j.1525-1470.2012.01819.x.
5.
ShojiKKomuroHMiyataIMiyairiISaitohA.Dermatologic manifestations of human parechovirus type 3 infection in neonates and infants. Pediatr Infect Dis J. 2013;32(3):233-236. doi:10.1097/INF.0b013e31827b1fd0.
KalpatthiRKissJE.Thrombotic thrombocytopenic purpura, heparin-induced thrombocytopenia, and disseminated intravascular coagulation. Crit Care Clin. 2020;36(2):357-377. doi:10.1016/j.ccc.2019.12.006.
8.
BlackCGTavaresLStachelARatnerAJRandisTM.Distribution of late-onset neonatal sepsis pathogens differs in inpatient and outpatient settings. Am J Perinatol. 2019;36(11):1136-1141. doi:10.1055/s-0038-1675643.
9.
MassaadMJRameshNGehaRS.Wiskott-Aldrich syndrome: a comprehensive review. Ann N Y Acad Sci. 2013;1285:26-43. doi:10.1111/nyas.12049.
10.
FreemanMCMitchellSIbrahimJWilliamsJV.Neonatal toxic shock syndrome-like exanthematous disease in North America. J Pediatric Infect Dis Soc. 2021;10(2):205-206. doi:10.1093/jpids/piz060.
11.
TakahashiNUeharaRNishidaH, et al. Clinical features of neonatal toxic shock syndrome-like exanthematous disease emerging in Japan. J Infect. 2009;59(3):194-200. doi:10.1016/j.jinf.2009.06.010.
12.
TakahashiNNishidaHKatoHImanishiKSakataYUchiyamaT.Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period. Lancet. 1998;351(9116):1614-1619. doi:10.1016/S0140-6736(97)11125-4.
13.
BešićHParo-PanjanDNosanG.Neonatal toxic shock syndrome-like exanthematous disease: a report of two cases. Pediatr Infect Dis J. 2023;42(4):e114-e115. doi:10.1097/INF.0000000000003817.
14.
van der Mee-MarquetNLinaGQuentinR, et al. Staphylococcal exanthematous disease in a newborn due to a virulent methicillin-resistant Staphylococcus aureus strain containing the TSST-1 gene in Europe: an alert for neonatologists. J Clin Microbiol. 2003;41:4883-4884.
15.
TakahashiNImanishiKUchiyamaT.Overall picture of an emerging neonatal infectious disease induced by a superantigenic exotoxin mainly produced by methicillin-resistantStaphylococcus aureus. Microbiol Immunol. 2013;57(11):737-745. doi:10.1111/1348-0421.12094.
16.
GerardRLehoursPBoraleviFSarlangueJ.Neonatal toxic shock syndrome-like exanthematous disease: a French case series. Pediatr Dermatol. 2023;40(2):349-351. doi:10.1111/pde.15165.
GaensbauerJTBirkholzMSmitMAGarciaRToddJK.Epidemiology and clinical relevance of toxic shock syndrome in US children. Pediatr Infect Dis J. 2018;37(12):1223-1226. doi:10.1097/INF.0000000000002002.
